XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Current Assets:    
Cash and cash equivalents $ 34.4 $ 64.4
Accounts receivable, less allowances of $6.1 and $5.3, respectively 278.8 266.3
Inventories 666.5 611.9
Notes receivable — net 6.7 10.6
Other current assets 46.6 45.3
Total current assets 1,033.0 998.5
Property, plant and equipment - net 366.1 335.3
Operating lease right-of-use assets 59.7 45.2
Goodwill 79.6 80.1
Intangible assets - net 125.6 126.7
Other non-current assets 42.7 29.7
Total assets 1,706.7 1,615.5
Current Liabilities:    
Accounts payable and accrued expenses 457.4 446.4
Customer advances 19.2 21.9
Short-term borrowings and current portion of long-term debt 13.4 6.1
Product warranties 47.1 48.8
Other liabilities 26.2 24.6
Total current liabilities 563.3 547.8
Non-Current Liabilities:    
Long-term debt 358.7 379.5
Operating lease liabilities 47.2 34.3
Deferred income taxes 7.5 4.9
Pension obligations 55.8 51.7
Postretirement health and other benefit obligations 5.6 8.2
Long-term deferred revenue 24.1 15.6
Other non-current liabilities 41.2 35.7
Total non-current liabilities 540.1 529.9
Commitments and contingencies (Note 19)
Total stockholders' equity:    
Preferred stock (3,500,000 shares authorized of $.01 par value; none outstanding) 0.0 0.0
Common stock (75,000,000 shares authorized, 40,793,983 shares issued, 35,094,993 and 35,085,008 shares outstanding, respectively) 0.4 0.4
Additional paid-in capital 613.1 606.7
Accumulated other comprehensive loss (86.4) (107.9)
Retained earnings 143.5 104.3
Treasury stock, at cost (5,698,990 and 5,708,975 shares, respectively) (67.3) (65.7)
Total stockholders’ equity 603.3 537.8
Total liabilities and stockholders' equity $ 1,706.7 $ 1,615.5